Compare Heron Therapeutics Inc (HRTX) vs Star Bulk Carriers Corp (SBLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Star Bulk Carriers Corp — how do they compare? Heron Therapeutics Inc trades at $0.4 (market cap $68.01M), while Star Bulk Carriers Corp trades at $29.91 (market cap $3.54B). The key difference: Star Bulk Carriers Corp is far larger — about 52.1× Heron Therapeutics Inc's market cap, and Star Bulk Carriers Corp pays a 6.17% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Star Bulk Carriers Corp for 24 Days on average.
| HRTX | SBLK | |
|---|---|---|
Market Cap | $68.01M | $3.54B |
Volume | 1,891,941 | 1,437,622 |
Sector | Health | Industrials |
52-Week High | $1.49 | $32.49 |
52-Week Low | $0.27 | $16.79 |
Typical Hold Time | 35 Days | 24 Days |
Enterprise Value | $174.75M | $4.22B |
Dividend Yield | — | 6.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Heron Therapeutics (HRTX) trades at $0.39, up 0.95% with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7M but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings discussions.
The outlook remains challenged by persistent losses and negative margins, though strong analyst support suggests potential upside. Key risks include execution on sales targets and achieving profitability. The stock's low price near 52-week lows presents speculative opportunity but requires careful risk management given financial performance.
Star Bulk Carriers (SBLK) trades at $29.86, up 0.57% today, with a bullish technical signal from moving averages and a neutral RSI. The company demonstrates strong fundamentals, with Q2 2026 EPS of $1.21 beating expectations and a net income margin of 23.87%. Recent news highlights insider buying and a declared $0.90 dividend, reflecting confidence in the shipping sector's momentum.
The outlook for SBLK is positive, supported by robust earnings growth, attractive valuation metrics like a P/E of 11.95, and a high analyst buy consensus of 58.34%. Key risks include exposure to volatile shipping rates and macroeconomic pressures, but the company's solid cash flow and dividend policy offer shareholder value. Upside potential hinges on continued operational execution and market conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Star Bulk Carriers Corp
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →
